Datasets | Source | Constituents | Purpose—in this study |
---|---|---|---|
Dataset A | Pride ID—PXD002952 | 3 samples of 65% human, 30% yeast, 5% E. coli peptides (Control) 3 samples of 65% human, 15% yeast, 20% E. coli peptides (Test) | Reference set—a well-defined dataset with predictable quantification |
Dataset B | In vitro experiments carried out in this study | 3 samples of K562/S cells (Control) 3 samples K562/S + IM cells (Test) | Study set to check comparability of observations in defined (A) versus undefined (B) datasets |
Dataset C | In vitro experiments carried out in this study | 12 samples of K562/S cells (Control) 12 samples K562/S + IM cells (Test) | Larger dataset (C) to check the application of observations from small dataset (B) |
Dataset D | In vitro experiments carried out in this study | 12 samples of K562/S + IM cells (Control) 12 samples K562/R cells (Test) | Larger dataset (D) to check the consistency of observations in independent large datasets |
Dataset E | Pride ID—PXD006106 | 10 samples of untreated HeLa Kyoto cells (Control) 10 samples of formaldehyde treated HeLa Kyoto cells (Test) | Validation set to check the consistency of observations in independent large datasets |
Dataset F | Pride ID—PXD000672 | 18 non-tumorous kidney tissue samples (Control) 18 tumorous kidney tissue samples (Test) | Validation set to check the consistency of observations in independent large datasets |